drugset / Trial / NCT03443843
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate changes in nasal airflow caused by loratadine 5 mg/pseudoephedrine sulfate 120 mg (Claritin D) tablet and fluticasone propionate 50 mcg per spray nasal spray (Flonase) in subjects suffering from nasal congestion and other allergy symptoms.
Timeline
- Start
- 2018-02-21
- Primary completion
- 2018-05-11
- Completion
- 2018-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 50 ug | Intranasal |
| Subject | Loratadine | Small molecule | 5 mg | Oral |
| Subject | Pseudoephedrine | Small molecule | 120 mg | Oral |